|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) DNA.|
|FSP, GRO1, GROa, MGSA, NAP-3, SCYB1, MGSA-a, CXCL1|
|pMD18-T Simple Vector|
|Identical with the Gene Bank Ref. ID sequence.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
pMD18-T Simple Vector is a high-efficiency TA cloning vector constructed from pUC18, of which the initial multiple cloning sites (MCS) were destroyed. Thus the cDNA should be amplified by PCR with primers containing a restriction site for subclone. Competent cells appropriate for pUC18 are also appropriated for the Vector, e.g. JM109, DH5α, TOP10. The pMD18-T Simple Vector is 2.6kb in size. Selection of the plasmid in E. coli is conferred by the ampicillin resistance gene. The coding sequence was inserted by TA cloning at site 425.
The coding sequence can be amplified by PCR with M13-47 and RV-M primers.
|Human CXCL1 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG10877-M-F|
|Human CXCL1 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG10877-M-H|
|Human CXCL1 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG10877-M-M|
|Human CXCL1 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG10877-M-N|
|Human CXCL1 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG10877-M-Y|
|Product name||Product name|
The Chemokine (C-X-C motif) Ligand 1, CXCL1, is a small cytokine belonging to the CXC chemokine family that was previously called GRO1 oncogene, GRO?, KC, Neutrophil-activating protein 3 (NAP-3) and melanoma growth stimulating activity, alpha (MSGA-a). CXCL1 already known to be important in osteoarthritis (OA), as a novel target gene of transcription factor AP-2? in chondrocytes and support the important role of AP-2? in cartilage. CXCL1 is a potent neutrophil chemoattractant with recognized roles in angiogenesis and inflammation. CXCL1 is a novel immediate PTH/PTHrP-responsive gene. CXCL1 may act as a chemoattractant for osteoclast precursors. CXCL1 may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis. CXCL1 plays a critical nonredundant role in the development of experimental Lyme arthritis and carditis via CXCR2-mediated recruitment of neutrophils into the site of infection. CXCL1 functions through CXCR2 to transactivate the EGFR by proteolytic cleavage of HB-EGF, leading to activation of MAPK signalling and increased proliferation of epithelial ovarian cancer (EOC) cells. It might limit tumor growth by reinforcing senescence early in tumorigenesis. Thus, CXCL1 plays a role in spinal cord development by inhibiting the migration of oligodendrocyte precursors and is involved in the processes of angiogenesis, inflammation, wound healing, and tumorigenesis.